91 related articles for article (PubMed ID: 28558204)
1. Development and Application of Synthetic Affinity Ligands for the Purification of Ferritin-Based Influenza Antigens.
Jacob SI; Khogeer B; Bampos N; Sheppard T; Schwartz R; Lowe CR
Bioconjug Chem; 2017 Jul; 28(7):1931-1943. PubMed ID: 28558204
[TBL] [Abstract][Full Text] [Related]
2. Affinity ligands for glycoprotein purification based on the multi-component Ugi reaction.
Chen C; Khoury GE; Lowe CR
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():171-80. PubMed ID: 25173497
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and assessment of a de novo affinity adsorbent for the purification of recombinant human erythropoietin.
El Khoury G; Wang Y; Wang D; Jacob SI; Lowe CR
Biotechnol Bioeng; 2013 Nov; 110(11):3063-9. PubMed ID: 23613257
[TBL] [Abstract][Full Text] [Related]
4. Progress on adenovirus-vectored universal influenza vaccines.
Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
6. A synthetic Protein G adsorbent based on the multi-component Ugi reaction for the purification of mammalian immunoglobulins.
Qian J; El Khoury G; Issa H; Al-Qaoud K; Shihab P; Lowe CR
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():15-23. PubMed ID: 22575289
[TBL] [Abstract][Full Text] [Related]
7. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin.
Song L; Xiong D; Kang X; Yang Y; Wang J; Guo Y; Xu H; Chen S; Peng D; Pan Z; Jiao X
BMC Biotechnol; 2015 Aug; 15():79. PubMed ID: 26286143
[TBL] [Abstract][Full Text] [Related]
8. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns.
Kalashnikova I; Ivanova N; Tennikova T
Anal Chem; 2008 Mar; 80(6):2188-98. PubMed ID: 18271603
[TBL] [Abstract][Full Text] [Related]
9. A theoretical and experimental approach toward the development of affinity adsorbents for GFP and GFP-fusion proteins purification.
Fernandes CS; Pina AS; Dias AM; Branco RJ; Roque AC
J Biotechnol; 2014 Sep; 186():13-20. PubMed ID: 24992212
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
[TBL] [Abstract][Full Text] [Related]
11. Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase.
Dalakouras T; Smith BJ; Platis D; Cox MM; Labrou NE
J Chromatogr A; 2006 Dec; 1136(1):48-56. PubMed ID: 17046775
[TBL] [Abstract][Full Text] [Related]
12. A biomimetic Protein G affinity adsorbent: an Ugi ligand for immunoglobulins and Fab fragments based on the third IgG-binding domain of Protein G.
El Khoury G; Lowe CR
J Mol Recognit; 2013 Apr; 26(4):190-200. PubMed ID: 23456743
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
14. Affinity ligands for immunoglobulins based on the multicomponent Ugi reaction.
Haigh JM; Hussain A; Mimmack ML; Lowe CR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1440-52. PubMed ID: 19345158
[TBL] [Abstract][Full Text] [Related]
15. Purification of human erythropoietin by affinity chromatography using cyclic peptide ligands.
Kish WS; Roach MK; Sachi H; Naik AD; Menegatti S; Carbonell RG
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():1-12. PubMed ID: 29625371
[TBL] [Abstract][Full Text] [Related]
16. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
17. Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice.
Subathra M; Santhakumar P; Satyam Naidu S; Lakshmi Narasu M; Senthilkumar TM; Lal SK
Appl Biochem Biotechnol; 2014 Apr; 172(7):3635-45. PubMed ID: 24562978
[TBL] [Abstract][Full Text] [Related]
18. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
20. Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.
Pua TL; Chan XY; Loh HS; Omar AR; Yusibov V; Musiychuk K; Hall AC; Coffin MV; Shoji Y; Chichester JA; Bi H; Streatfield SJ
Hum Vaccin Immunother; 2017 Feb; 13(2):306-313. PubMed ID: 27929750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
